Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telbivudine Extension Study in Chronic Hepatitis B
NCT00877149Phase 4Completed
- Sponsor
- Novartis
- Start
- Mar 2009
- Primary completion
- Apr 2011
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of telbivudine in Chronic Hepatitis B (CHB), sponsored by Novartis. Started Mar 2009; status: completed.
02
Drugs
telbivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00877149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00877149.